Desq Long
Sign in
SEC FORM 4
$10,167.20

CRESCENT BIOPHARMA, INC. (CBIO)

Sale of 568 shares at $17.90 per share.

Reporting Person Scalzo Richard William · Officer Title Chief Financial Officer · Transaction Code S

Traded Sep 16, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001628280-26-062705 · filed 2026-09-18 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "CRESCENT BIOPHARMA, INC. (CBIO)." Disclosed 2026-09-18. https://desqlong.com/cards/0001628280-26-062705-1 (retrieved 2026-09-26).